Mestag Therapeutics

Mestag Therapeutics is dedicated to pioneering new therapies for inflammatory diseases and cancer by expertly targeting fibroblast immunology. Leveraging a profound understanding of fibroblast-immune interactions, Mestag Therapeutics is committed to developing innovative treatments. The company is advancing a pipeline of first-in-class antibody programs and targets, poised to revolutionize patient care.

Located in London, GB, Cambridge, GB, and Boston, US, Mestag Therapeutics is backed by leading global investors, world-class founders, and a highly experienced leadership team. Mestag Therapeutics fosters an exciting, diverse, and balanced work environment, offering competitive benefits, generous vacation time, and ample opportunities for career growth and development.

Mestag Therapeutics is rapidly establishing itself as a leader in biotechnology research. The company's commitment to innovation and excellence ensures that it will continue to make significant contributions to the field. We invite the management team at Mestag Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.